Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs NEULAND LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA NEULAND LABS DISHMAN PHARMA/
NEULAND LABS
 
P/E (TTM) x 30.0 26.4 113.6% View Chart
P/BV x 3.3 2.6 128.2% View Chart
Dividend Yield % 0.7 0.3 227.2%  

Financials

 DISHMAN PHARMA   NEULAND LABS
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
NEULAND LABS
Mar-22
DISHMAN PHARMA/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs3742,840 13.2%   
Low Rs1291,000 12.9%   
Sales per share (Unadj.) Rs197.0741.3 26.6%  
Earnings per share (Unadj.) Rs21.249.7 42.6%  
Cash flow per share (Unadj.) Rs34.788.0 39.5%  
Dividends per share (Unadj.) Rs2.005.00 40.0%  
Avg Dividend yield %0.80.3 305.2%  
Book value per share (Unadj.) Rs179.9655.1 27.5%  
Shares outstanding (eoy) m80.7012.83 629.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.32.6 49.3%   
Avg P/E ratio x11.938.6 30.8%  
P/CF ratio (eoy) x7.321.8 33.2%  
Price / Book Value ratio x1.42.9 47.7%  
Dividend payout %9.410.1 93.9%   
Avg Mkt Cap Rs m20,30724,633 82.4%   
No. of employees `000NANA-   
Total wages/salary Rs m5,3551,825 293.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,8989,511 167.2%  
Other income Rs m26521 1,277.8%   
Total revenues Rs m16,1639,532 169.6%   
Gross profit Rs m4,1031,426 287.7%  
Depreciation Rs m1,091490 222.4%   
Interest Rs m944135 699.8%   
Profit before tax Rs m2,334822 284.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624183 340.0%   
Profit after tax Rs m1,710638 267.9%  
Gross profit margin %25.815.0 172.1%  
Effective tax rate %26.722.3 119.7%   
Net profit margin %10.86.7 160.3%  
BALANCE SHEET DATA
Current assets Rs m11,0185,828 189.1%   
Current liabilities Rs m9,5173,632 262.1%   
Net working cap to sales %9.423.1 40.9%  
Current ratio x1.21.6 72.1%  
Inventory Days Days5714 413.5%  
Debtors Days Days3899 0.4%  
Net fixed assets Rs m18,7878,007 234.6%   
Share capital Rs m161129 125.1%   
"Free" reserves Rs m14,3548,276 173.4%   
Net worth Rs m14,5168,405 172.7%   
Long term debt Rs m4,1891,042 401.9%   
Total assets Rs m29,80513,835 215.4%  
Interest coverage x3.57.1 49.0%   
Debt to equity ratio x0.30.1 232.7%  
Sales to assets ratio x0.50.7 77.6%   
Return on assets %8.95.6 159.4%  
Return on equity %11.87.6 155.1%  
Return on capital %17.510.1 173.1%  
Exports to sales %24.972.1 34.5%   
Imports to sales %3.717.0 22.0%   
Exports (fob) Rs m3,9566,858 57.7%   
Imports (cif) Rs m5941,613 36.8%   
Fx inflow Rs m4,9526,858 72.2%   
Fx outflow Rs m6971,613 43.2%   
Net fx Rs m4,2555,245 81.1%   
CASH FLOW
From Operations Rs m2,786586 475.6%  
From Investments Rs m-1,529-937 163.2%  
From Financial Activity Rs m-941377 -249.5%  
Net Cashflow Rs m31727 1,191.6%  

Share Holding

Indian Promoters % 61.4 36.2 169.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 23.0 24.7 92.9%  
FIIs % 12.0 17.7 67.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 63.8 60.5%  
Shareholders   52,291 30,600 170.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    


More on Dishman Pharma vs NEULAND LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs NEULAND LABS Share Price Performance

Period Dishman Pharma NEULAND LABS S&P BSE HEALTHCARE
1-Day 2.87% -1.55% -0.10%
1-Month -2.45% 16.29% -1.99%
1-Year 96.38% -5.77% -5.62%
3-Year CAGR 50.28% 56.57% 20.96%
5-Year CAGR 41.17% 13.38% 11.47%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the NEULAND LABS share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of NEULAND LABS the stake stands at 36.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of NEULAND LABS.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

NEULAND LABS paid Rs 5.0, and its dividend payout ratio stood at 10.1%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of NEULAND LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.